Drugs / Labinic (R)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04172012 Comparator | Feb 2022 → Jul 2023 | neonatal sepsis | Haydom Lutheran Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Labinic (R) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04172012 ↗ |
| Modality | Other / unclassified | “multistrain probiotic mixture” PMID 40412397 ↗ Jun 2025 |
| Route | Oral | “Caregivers were shown how to give five drops (0·2 mL) of allocated treatment solution orally to their infant” PMID 40412397 ↗ Jun 2025 |